Skip to content
Skip to navigation
Skip to footer

Archive

View global media contacts

Home / Media Centre / Archive

Here you can find the archive of all Press Releases prior to 2023

Filter by date:

Showing 1239 press releases before 2023

AstraZeneca announces top-line results from SATURN study
2 September 2011
Sale of Astra Tech to DENTSPLY International complete
31 August 2011
Positive agreement received for approval of AXANUM (low-dose ASA/esomeprazole) in Europe
2 August 2011
AstraZeneca PLC Second quarter and half year results 2011
28 July 2011
FDA approves new medicine BRILINTA (ticagrelor) for use in the US
20 July 2011
FDA Advisory Committee makes recommendation on investigational compound dapagliflozin
20 July 2011
AstraZeneca's NEXIUM receives first regulatory approval in Japan for the treatment of acid-related diseases
1 July 2011
Bristol Myers Squibb and AstraZeneca announce investigational compound DAPAGLIFLOZIN sustained glycemic control and weight reduction in study of Type2 Diabetes patients inadequately controlled with metformin
27 June 2011
AstraZeneca to sell AstraTech to DENTSPLY International
22 June 2011
AstraZeneca extends its investment in Russia with new predictive science centre in St Petersburg
16 June 2011

<
1
2
3
124
>

All of our latest press releases and articles are available to explore